NASDAQ:ONCO • US68237Q2030
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ONCONETIX INC (ONCO).
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 58.5K | 2.524M 4,214.70% | -100.00% | ||
| EBITDA YoY % growth | -13.47M -293.86% | -17.803M -32.17% | -9.6M 46.08% | N/A | |
| EBIT YoY % growth | -13.48M -294.15% | -17.847M -32.40% | -10.331M 42.11% | -20.645M -99.83% | |
| Operating Margin | N/A | -30,508.03% | -409.30% | N/A | |
| EPS YoY % growth | N/A | N/A 99.98% | N/A -11.84% | -1.01 -16.47% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
ONCONETIX INC (ONCO) will report earnings on 2026-06-01, after the market close.
The number of analysts covering ONCONETIX INC (ONCO) is 6.